Role of CABG in the management of obstructive coronary arterial disease in patients with diabetes mellitus

被引：7

作者：

Aronson, Doron ^{[1
,2
]}

Edelman, Elazer R. ^{[3
,4
]}

机构：

[1] Technion Israel Inst Technol, Rambam Med Ctr, Dept Cardiol, Haifa, Israel

[2] Technion Israel Inst Technol, Rappaport Res Inst, Haifa, Israel

[3] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA

[4] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc,Dept Med, Cambridge, MA 02138 USA

来源：

CURRENT OPINION IN PHARMACOLOGY | 2012年 / 12卷 / 02期

关键词：

INTERNAL THORACIC ARTERY; INTENSIVE INSULIN THERAPY; GLUCAGON-LIKE PEPTIDE-1; GLYCEMIC CONTROL; BYPASS SURGERY; MYOCARDIAL-INFARCTION; EUROPEAN ASSOCIATION; CONSENSUS STATEMENT; GLUCOSE MANAGEMENT; PRACTICE GUIDELINE;

D O I：

10.1016/j.coph.2012.01.011

中图分类号：

R9 [药学];

学科分类号：

100702 [药剂学];

摘要：

Multiple studies have shown that diabetes mellitus (DM) can affect the efficacy of revascularization therapies and subsequent clinical outcomes. Selection of the appropriate myocardial revascularization strategy is critically important in the setting of multivessel coronary disease. Optimal medical therapy is an appropriate first-line strategy in patients with DM and mild symptoms. When medical therapy does not adequately control symptoms, revascularization with either PCI or CABG may be used. In patients with treated DM, moderate to severe symptoms and complex multivessel coronary disease, coronary artery bypass graft surgery provides better survival, fewer recurrent infarctions and greater freedom from re-intervention. Decisions regarding revascularization in patients with DM must take into account multiple factors and as such require a multidisciplinary team approach ('heart team').

引用

页码：134 / 141

页数：8

共 59 条

[1]

Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease - The bypass angioplasty revascularization investigation (BARI) [J].

Alderman, E ;

Bourassa, M ;

Brooks, MM ;

Califf, R ;

Chaitman, B ;

Detre, K ;

Faxon, DP ;

Feit, F ;

Frye, RL ;

Hardison, RM ;

Holmes, D ;

Holubkov, R ;

Kouchoukos, N ;

Krone, R ;

Rogers, W ;

Rosen, AD ;

Schaff, H ;

Schwartz, L ;

Siewers, AS ;

Sopko, G ;

SuttonTyrrell, K ;

Whitlow, P .

CIRCULATION, 1997, 96 (06) :1761-1769

[2]

Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc19-S002, 10.2337/dc12-S064, 10.2337/dc23-S002, 10.2337/dc09-S062, 10.2337/dc18-S002]

[3]

Potential mechanisms promoting restenosis in diabetic patients [J].